• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心理社会功能的早期改善预示着抑郁症患者更长期的症状缓解。

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients.

作者信息

Jha Manish K, Minhajuddin Abu, Greer Tracy L, Carmody Thomas, Rush Augustus John, Trivedi Madhukar H

机构信息

Department of Psychiatry, UT Southwestern Medical Center, Dallas, Texas, United States of America.

Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, Texas, United States of America.

出版信息

PLoS One. 2016 Dec 28;11(12):e0167901. doi: 10.1371/journal.pone.0167901. eCollection 2016.

DOI:10.1371/journal.pone.0167901
PMID:28030546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5193346/
Abstract

The goal of this study was to evaluate the relationship between early change in psychosocial function independent of depression severity and longer-term symptomatic remission. Participants of Combining Medications to Enhance Depression Outcomes trial were randomly selected for model selection (n = 334) and validation (n = 331). Changes in psychosocial function (Work and Social Adjustment Scale, WSAS) from baseline to week 6 were assessed and two data-driven sub-groups of WSAS change were identified in the randomly selected model selection half. Results of analyses to predict symptomatic remission at 3 and 7 months were validated for these sub-groups in the second half (validation sample). From baseline to week 6, psychosocial function improved significantly even after adjusting for depression severity at each visit and select baseline variables (age, gender, race, ethnicity, education, income, employment, depression onset before age 18, anxious features, and suicidal ideation), treatment-arm, and WSAS score. The WSAS change patterns identified two (early improvement and gradual change) subgroups. After adjusting for baseline variables and remission status at week 6, participants with early improvement in the second half (validation sample) had greater remission rates than those with gradual change at both 3 (3.3 times) and 7 months (2.3 times) following acute treatment initiation. In conclusion, early improvement in psychosocial function provides a clinically meaningful prediction of longer-term symptomatic remission, independent of depression symptom severity.

摘要

本研究的目的是评估独立于抑郁严重程度的心理社会功能早期变化与长期症状缓解之间的关系。“联合用药增强抑郁疗效”试验的参与者被随机选取用于模型选择(n = 334)和验证(n = 331)。评估从基线到第6周心理社会功能的变化(工作和社会适应量表,WSAS),并在随机选取的模型选择组中确定了两个由数据驱动的WSAS变化亚组。对预测3个月和7个月时症状缓解情况的分析结果在另一半(验证样本)的这些亚组中进行了验证。从基线到第6周,即使在对每次访视时的抑郁严重程度以及选定的基线变量(年龄、性别、种族、民族、教育程度、收入、就业情况、18岁前抑郁发作、焦虑特征和自杀意念)、治疗组和WSAS评分进行调整后,心理社会功能仍有显著改善。WSAS变化模式确定了两个亚组(早期改善组和逐渐变化组)。在对基线变量和第6周的缓解状态进行调整后,后半部分(验证样本)中早期改善的参与者在急性治疗开始后的3个月(3.3倍)和7个月(2.3倍)时的缓解率均高于逐渐变化的参与者。总之,心理社会功能的早期改善提供了对长期症状缓解的具有临床意义的预测,且独立于抑郁症状的严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a66b/5193346/3a5d3e2c6e1e/pone.0167901.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a66b/5193346/cc9a5417b794/pone.0167901.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a66b/5193346/3a5d3e2c6e1e/pone.0167901.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a66b/5193346/cc9a5417b794/pone.0167901.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a66b/5193346/3a5d3e2c6e1e/pone.0167901.g002.jpg

相似文献

1
Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients.心理社会功能的早期改善预示着抑郁症患者更长期的症状缓解。
PLoS One. 2016 Dec 28;11(12):e0167901. doi: 10.1371/journal.pone.0167901. eCollection 2016.
2
Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial.生活质量的早期正常化预示着抑郁症的后期缓解:来自CO-MED试验的结果。
J Affect Disord. 2016 Dec;206:17-22. doi: 10.1016/j.jad.2016.07.012. Epub 2016 Jul 5.
3
Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.激惹及其在重性抑郁障碍中的临床应用:使用激惹和抑郁严重程度的早期变化预测个体急性期结局。
Am J Psychiatry. 2019 May 1;176(5):358-366. doi: 10.1176/appi.ajp.2018.18030355. Epub 2019 Mar 29.
4
Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial.工作效率的早期改善可预测抑郁症门诊患者的未来临床病程:CO-MED试验的结果
Am J Psychiatry. 2016 Dec 1;173(12):1196-1204. doi: 10.1176/appi.ajp.2016.16020176. Epub 2016 Aug 13.
5
Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials.基于症状测量增加单一活动障碍指标预测急性期治疗结局:来自 STAR*D 和 CO-MED 试验的交互式计算器的开发和验证。
Int J Neuropsychopharmacol. 2019 May 1;22(5):339-348. doi: 10.1093/ijnp/pyz011.
6
Novel Augmentation Strategies in Major Depression.重度抑郁症的新型强化治疗策略
Dan Med J. 2017 Apr;64(4).
7
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.抗抑郁药引发的早期改善能否预测疗效/缓解情况?对大量重度抑郁症住院患者的自然主义研究数据进行分析。
J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.
8
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.抗抑郁药治疗对随机试验中自杀意念和行为的影响:来自联合用药以增强抑郁结局研究的探索性报告。
J Clin Psychiatry. 2011 Oct;72(10):1322-32. doi: 10.4088/JCP.10m06724.
9
The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?度洛西汀对抑郁症患者疼痛性躯体症状的影响:这些症状的改善是否会导致更高的缓解率?
J Clin Psychiatry. 2004 Apr;65(4):521-30. doi: 10.4088/jcp.v65n0411.
10
BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.接受度文拉法辛治疗的抑郁患者的 BDNF、白细胞介素-6 和唾液皮质醇水平。
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:86-91. doi: 10.1016/j.pnpbp.2013.09.016. Epub 2013 Oct 2.

引用本文的文献

1
Longitudinal bidirectional association between psychosocial function and depression in Chinese patients with clinically remitted depression: a cross-lagged panel model analysis.中国临床缓解期抑郁症患者心理社会功能与抑郁之间的纵向双向关联:交叉滞后面板模型分析
BMC Psychiatry. 2025 Mar 21;25(1):270. doi: 10.1186/s12888-025-06694-7.
2
The Work and Social Adjustment Scale (WSAS): An investigation of reliability, validity, and associations with clinical characteristics in psychiatric outpatients.工作和社会适应量表(WSAS):在精神科门诊患者中调查其信度、效度和与临床特征的关联。
PLoS One. 2024 Oct 10;19(10):e0311420. doi: 10.1371/journal.pone.0311420. eCollection 2024.
3

本文引用的文献

1
Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial.工作效率的早期改善可预测抑郁症门诊患者的未来临床病程:CO-MED试验的结果
Am J Psychiatry. 2016 Dec 1;173(12):1196-1204. doi: 10.1176/appi.ajp.2016.16020176. Epub 2016 Aug 13.
2
IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY.运动强化治疗对治疗有反应但未缓解的重度抑郁症患者心理社会功能及健康相关生活质量的改善:TREAD研究结果
Depress Anxiety. 2016 Sep;33(9):870-81. doi: 10.1002/da.22521. Epub 2016 May 10.
3
Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics.
精神科药物研发中的生物标志物:从精准医学到新型疗法
Adv Neurobiol. 2023;30:287-297. doi: 10.1007/978-3-031-21054-9_12.
4
Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study.简明相关症状追踪量表的心理测量特性及在EMBARC研究中的临床效用验证
Psychiatr Res Clin Pract. 2020 Sep 9;2(1):10-18. doi: 10.1176/appi.prcp.20190041. eCollection 2020 Summer.
5
Remission of symptoms is not equal to functional recovery: Psychosocial functioning impairment in major depression.症状缓解不等于功能恢复:重度抑郁症中的心理社会功能损害
Front Psychiatry. 2022 Jul 26;13:915689. doi: 10.3389/fpsyt.2022.915689. eCollection 2022.
6
Development of a psychosocial functioning questionnaire for patients with major depressive disorder.重度抑郁症患者心理社会功能问卷的编制
Gen Psychiatr. 2022 Feb 25;35(1):e100527. doi: 10.1136/gpsych-2021-100527. eCollection 2022.
7
Validation of the German version of the work and social adjustment scale in a sample of depressed patients.验证工作和社会调整量表的德文版在一组抑郁患者中的适用性。
BMC Health Serv Res. 2021 Jun 21;21(1):593. doi: 10.1186/s12913-021-06622-x.
8
Cross-Sectional Associations Among Symptoms of Pain, Irritability, and Depression and How These Symptoms Relate to Social Functioning and Quality of Life: Findings From the EMBARC and STRIDE Studies and the VitalSign6 Project.疼痛、易怒和抑郁症状之间的横断面关联,以及这些症状与社会功能和生活质量的关系:来自 EMBARC 和 STRIDE 研究以及 VitalSign6 项目的结果。
J Clin Psychiatry. 2021 Apr 13;82(3):20m13740. doi: 10.4088/JCP.20m13740.
9
Redefining Therapeutic Outcomes of Depression Treatment.重新定义抑郁症治疗的疗效
J Pers Oriented Res. 2019 Dec 30;5(2):1-8. doi: 10.17505/jpor.2019.10. eCollection 2019.
10
Spotlight on Pimavanserin Tartrate and Its Therapeutic Potential in the Treatment of Major Depressive Disorder: The Evidence to Date.聚焦匹伐他汀钙及其在治疗重度抑郁症中的治疗潜力:迄今为止的证据。
Drug Des Devel Ther. 2021 Jan 13;15:151-157. doi: 10.2147/DDDT.S240862. eCollection 2021.
Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters.
基于测量的护理与重度抑郁症的标准护理:一项有盲法评估者的随机对照试验。
Am J Psychiatry. 2015 Oct;172(10):1004-13. doi: 10.1176/appi.ajp.2015.14050652. Epub 2015 Aug 28.
4
PSYCHOLOGY. Estimating the reproducibility of psychological science.心理学. 心理科学可重复性的评估.
Science. 2015 Aug 28;349(6251):aac4716. doi: 10.1126/science.aac4716.
5
Moderation of the Relationship Between Reward Expectancy and Prediction Error-Related Ventral Striatal Reactivity by Anhedonia in Unmedicated Major Depressive Disorder: Findings From the EMBARC Study.未用药的重度抑郁症患者中快感缺失对奖赏预期与预测误差相关腹侧纹状体反应性之间关系的调节作用:来自EMBARC研究的结果
Am J Psychiatry. 2015 Sep 1;172(9):881-91. doi: 10.1176/appi.ajp.2015.14050594. Epub 2015 Jul 17.
6
Distinguishing functional from syndromal recovery: implications for clinical care and research.区分功能恢复与综合征恢复:对临床护理和研究的意义。
J Clin Psychiatry. 2015 Jun;76(6):e832-4. doi: 10.4088/JCP.15com09859.
7
The relationship between symptom relief and functional improvement during acute fluoxetine treatment for patients with major depressive disorder.重度抑郁症患者急性氟西汀治疗期间症状缓解与功能改善之间的关系。
J Affect Disord. 2015 Aug 15;182:115-20. doi: 10.1016/j.jad.2015.04.022. Epub 2015 Apr 22.
8
Negative events in childhood predict trajectories of internalizing symptoms up to young adulthood: an 18-year longitudinal study.童年期的负面事件可预测直至青年期的内化症状轨迹:一项18年的纵向研究。
PLoS One. 2014 Dec 8;9(12):e114526. doi: 10.1371/journal.pone.0114526. eCollection 2014.
9
The work and social adjustment scale: reliability, sensitivity and value.工作和社会调整量表:信度、敏感性和效度。
Int J Psychiatry Clin Pract. 2014 Jun;18(2):131-8. doi: 10.3109/13651501.2014.894072. Epub 2014 Mar 16.
10
Data-driven course trajectories in primary care patients with major depressive disorder.数据驱动的主要抑郁障碍初级保健患者的课程轨迹。
Depress Anxiety. 2014 Sep;31(9):778-86. doi: 10.1002/da.22228. Epub 2014 Jan 3.